RecruitingNot ApplicableNCT02836262

Hip Replacement System (HRS-P) in Primary Total Hip Arthroplasty

A Multi-Center Prospective Study of the Hip Innovation Technology (HIT) Hip Replacement System in Primary Total Hip Arthroplasty

Sponsor

Hip Innovation Technology

Enrollment

100 participants

Start Date

Aug 25, 2017

Study Type

INTERVENTIONAL

Conditions

Osteoarthritis of Hip

Summary

To evaluate effectiveness and safety of HHRS in subjects undergoing total hip arthroplasty (THA). Effectiveness will be evaluated using patient-reported, clinical, radiologic, and radiostereometric outcomes. Safety will be evaluated through the collection of device-related and unanticipated device-related adverse events.

Eligibility

Min Age: 65 YearsMax Age: 79 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called HIT Hip Replacement System for people with osteoarthritis of hip. The study is currently recruiting participants at 1 location. People eligible for this study include aged 65 Years to 79 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEHIT Hip Replacement System

HIT Hip Replacement System

Locations(1)

Orthopaedic Innovation Centre

Winnipeg, Manitoba, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02836262

Related Trials

G7 Acetabular System With Vivacit-E or Longevity Liner PMCF Study

NCT0475408711 locations